Under the leadership of Richard Myers, PhD, HudsonAlpha connects these four endeavors into a single enterprise, making it one of the most unique areas for genomic discovery in the country. HudsonAlpha has generated major discoveries that impact disease diagnosis and treatment, created intellectual property, fostered biotechnology companies and expanded the number of biosciences-literate people, many of whom will take their place among the future life sciences workforce. Additionally, HudsonAlpha has created one of the world’s first end-to-end genomic medicine programs to diagnose rare disease. Genomic research, educational outreach, clinical genomics and economic development: each of these mission areas advances the quality of life. Together, they are powerfully synergistic and represent the science of progress at HudsonAlpha.